BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29631063)

  • 1. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases.
    Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E
    Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
    J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.
    Brito Fde A; Santos SM; Ferreira GA; Pedrosa W; Gradisse J; Costa LC; Neves SP
    Rev Bras Reumatol; 2014; 54(1):13-20. PubMed ID: 24878786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.
    de Almeida Brito F; Maria Elói Santos S; Aparecida Ferreira G; Pedrosa W; Gradisse J; Cristina Costa L; Pretti Figueiredo Neves S
    Am J Clin Pathol; 2016 Mar; 145(3):323-31. PubMed ID: 27124914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis.
    Fenger M; Wiik A; Høier-Madsen M; Lykkegaard JJ; Rozenfeld T; Hansen MS; Samsoe BD; Jacobsen S
    Clin Chem; 2004 Nov; 50(11):2141-7. PubMed ID: 15345663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
    J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.
    Yuan W; Cao H; Li W; Wu X; Zheng J
    Clin Rheumatol; 2022 Mar; 41(3):899-909. PubMed ID: 34626262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies in the diagnostics of rheumatic diseases].
    Rose T; Dörner T
    Z Rheumatol; 2020 Jun; 79(5):447-458. PubMed ID: 32458159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.
    Rohwäder E; Locke M; Fraune J; Fechner K
    Expert Rev Mol Diagn; 2015 Apr; 15(4):451-62. PubMed ID: 25530004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting.
    Barak M; Rozenberg O; Grinberg M; Reginashvili D; Kishinewsky M; Henig C; Froom P
    Clin Chem Lab Med; 2013 Jul; 51(7):e163-5. PubMed ID: 23045381
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
    Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
    Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Performance of the Line Immunoassay, Digital Liquid Chip Method, and Chemiluminescent Immunoassay for Detecting Specific Antinuclear Antibodies.
    Su Z; Wang L; Gao X; Huang Z; Hu J; Yang B
    Arch Pathol Lab Med; 2024 May; 148(5):566-572. PubMed ID: 37594897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: comment on the article by Mariz et al.
    Craig WY; Ledue TB
    Arthritis Rheum; 2011 Jun; 63(6):1759; author reply 1760. PubMed ID: 21425126
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
    Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
    Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization.
    Meroni PL; Borghi MO
    Clin Chem Lab Med; 2018 Sep; 56(10):1743-1748. PubMed ID: 29708880
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.